Cite Filings / NMRA
Feed Companies Filings Check
Sign in

CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company

Neumora Therapeutics, Inc.

Sign in to watch
Ticker
NMRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844367680
Phone
(857) 760-0900
Business address
260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
Filings Insiders Search text
All 258 Financials 46 Shareholder Meetings 4 Executive Compensation 40 Insider Trading 118 Beneficial Ownership Interest 21 Business Combinations 34 Public Offerings 13 Mutual Funds and ETFs 3 Others 59
›
Filed in
  1. No filings match these filters. Clear filters
  2. 424B4 Offering Prospectus 2023-09-18
  3. CORRESP Other Correspondence Between Filers and SEC Staff 2023-09-12
  4. CORRESP Other Correspondence Between Filers and SEC Staff 2023-09-12
  5. S-1/A Offering Registration Statement 2023-09-11
  6. CORRESP Other Correspondence Between Filers and SEC Staff 2023-08-25
  7. S-1 Offering Registration Statement 2023-08-25
  8. UPLOAD Other SEC-generated Letter 2023-08-17
  9. UPLOAD Other SEC-generated Letter 2023-07-12
  10. UPLOAD Other SEC-generated Letter 2023-05-24
  11. UPLOAD Other SEC-generated Letter 2022-06-17
  12. UPLOAD Other SEC-generated Letter 2022-05-16
  13. UPLOAD Other SEC-generated Letter 2022-01-07
  14. UPLOAD Other SEC-generated Letter 2021-12-06

Page 1 of 1 · 13 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…